OSR HEALTH, INC. Severance Costs
OSR HEALTH, INC. (OSRH) reported Severance Costs of $68.55 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2026-08-14
- OSR HEALTH, INC. severance costs for the quarter ending 2026-06-30 was $18.05K, a 67.40% decline year-over-year.
- OSR HEALTH, INC. severance costs for the quarter ending 2026-03-31 was $50.49K, a 66.80% decline year-over-year.
- OSR HEALTH, INC. severance costs for the quarter ending 2025-09-30 was -$29.33K, a 208.20% decline year-over-year.
- OSR HEALTH, INC. severance costs for the quarter ending 2025-06-30 was $55.38K, a 133.56% increase year-over-year.
- OSR HEALTH, INC. severance costs for fiscal 2024 was $80.71K.
| Period end | Severance Costs 3 month | Severance Costs 3 month as first filed | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $18.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $68.55K 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | $50.49K 10-Q · filed 2026-05-13 | ||||
| 2025-09-30 | -$29.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $26.05K derived: sum of 2 quarters · filed 2026-08-14 | $178.14K 10-Q · filed 2025-11-12 | $183.54K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $55.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $207.47K 10-Q · filed 2026-08-14 | $212.88K derived: sum of 3 quarters · filed 2026-08-14 | $239.99K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $152.09K 10-Q · filed 2026-05-13 | $152.09K 10-Q · filed 2025-05-20 | $157.49K derived: sum of 2 quarters · filed 2026-05-13 | $184.60K derived: sum of 3 quarters · filed 2026-05-13 | $208.32K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $5.41K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $32.52K derived: sum of 2 quarters · filed 2026-03-31 | $56.23K derived: sum of 3 quarters · filed 2026-03-31 | $80.71K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $27.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $50.82K derived: sum of 2 quarters · filed 2025-11-12 | $75.30K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $23.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $48.19K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | $24.48K 10-Q · filed 2025-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |